Florbetaben F 18

OTHER3 trials

Sponsors

Eli Lilly and Company

Conditions

Alzheimer DiseaseAmyloidHealthy VolunteersPlaque, AmyloidPlasma

Phase 1

A Study of LY4405094 in Healthy Participants and Participants With Alzheimer's Disease

RecruitingNCT07787182

Eli Lilly and CompanyAlzheimer Disease, Amyloid, Healthy Volunteers +1

Start: 2025-10-14End: 2028-01-01Target: 68Updated: 2026-10-22

A Master Protocol Studying Multiple Amyloid-Targeting Therapies in Healthy Participants and Participants With Alzheimer's Disease

RecruitingNCT07787169

Eli Lilly and CompanyAlzheimer Disease, Amyloid, Healthy Volunteers +1

Start: 2026-09-09End: 2028-07-01Target: 179Updated: 2026-10-08

A Study of LY4560736 in Healthy Participants and Participants With Alzheimer's Disease (AD)

Not yet recruitingNCT07843459

Eli Lilly and CompanyAlzheimer Disease, Amyloid, Healthy Volunteers +2

Start: 2026-10-01End: 2028-07-01Target: 111Updated: 2026-10-08